Silva-Velazco Jorge, Dietz David W, Stocchi Luca, Costedio Meagan, Gorgun Emre, Kalady Matthew F, Kessler Hermann, Lavery Ian C, Remzi Feza H
Department of Colorectal Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.
Ann Surg. 2017 May;265(5):960-968. doi: 10.1097/SLA.0000000000001815.
The aim of the study was to compare value (outcomes/costs) of proctectomy in patients with rectal cancer by 3 approaches: open, laparoscopic, and robotic.
The role of minimally invasive proctectomy in rectal cancer is controversial. In the era of value-based medicine, costs must be considered along with outcomes.
Primary rectal cancer patients undergoing curative intent proctectomy at our institution between 2010 and 2014 were included. Patients were grouped by approach [open surgery, laparoscopic surgery, and robotic surgery (RS)] on an intent-to-treat basis. Groups were compared by direct costs of hospitalization for the primary resection, 30-day readmissions, and ileostomy closure and for short-term outcomes.
A total of 488 patients were evaluated; 327 were men (67%), median age was 59 (27-93) years, and restorative procedures were performed in 333 (68.2%). Groups were similar in demographics, tumor characteristics, and treatment details. Significant outcome differences between groups were found in operative and anesthesia times (longer in the RS group), and in estimated blood loss, intraoperative transfusion, length of stay, and postoperative complications (all higher in the open surgery group). No significant differences were found in short-term oncologic outcomes. Direct cost of the hospitalization for primary resection and total direct cost (including readmission/ileostomy closure hospitalizations) were significantly greater in the RS group.
The laparoscopic and open approaches to proctectomy in patients with rectal cancer provide similar value. If robotic proctectomy is to be widely applied in the future, the costs of the procedure must be reduced.
本研究旨在比较直肠癌患者采用三种手术方式(开放手术、腹腔镜手术和机器人手术)进行直肠切除的价值(结果/成本)。
微创直肠切除术在直肠癌治疗中的作用存在争议。在基于价值的医学时代,必须同时考虑成本和结果。
纳入2010年至2014年在本机构接受根治性直肠切除术的原发性直肠癌患者。按治疗意向将患者分为手术方式组(开放手术、腹腔镜手术和机器人手术)。比较各组初次切除住院的直接成本、30天再入院率、回肠造口关闭情况以及短期结果。
共评估了488例患者;男性327例(67%),中位年龄59岁(27 - 93岁),333例(68.2%)进行了恢复性手术。各组在人口统计学、肿瘤特征和治疗细节方面相似。发现各组在手术和麻醉时间(机器人手术组较长)、估计失血量、术中输血、住院时间和术后并发症(开放手术组均较高)方面存在显著结果差异。短期肿瘤学结果无显著差异。机器人手术组初次切除住院的直接成本和总直接成本(包括再入院/回肠造口关闭住院)显著更高。
直肠癌患者采用腹腔镜和开放手术方式进行直肠切除的价值相似。如果未来机器人直肠切除术要广泛应用,必须降低该手术的成本。